30th Jan 2009 07:06
30 January 2009
Henderson Morley PLC
(the "Company")
Placing of new ordinary shares
Henderson Morley plc, the AIM quoted biotechnology company, announces that the Board has, today, issued and allotted a total of 146 million new ordinary shares through a Placing by Hybridan LLP to Institutional shareholders and other investors at 0.2 pence per share, raising £292,000 (gross) for the Company.
Andrew Knight and Dr Ian Pardoe, Directors of the Company, have each subscribed £50,000 for 25 million new ordinary shares as part of the Placing. It is intended that these shares will be held in their respective Self Invested Pension Plans. The Directors, other than Messrs Knight and Pardoe, having consulted with the Company's nominated adviser, believe that the terms of this transaction are fair and reasonable insofar as shareholders are concerned.
Following the Placing A Knight and Dr I Pardoe will own 111,153,764 and 74,727,751 shares respectively, representing 15.41% and 10.36% respectively of the Company's enlarged issued share capital of 721,261,963 shares in issue.
Mr Michael Dunne has also subscribed £20,000 for 10 million shares and is now interested in 6.44% of the Company's enlarged issued share capital.
The Placing is to fund additional working capital for the Company.
Application has been made for the new shares to be admitted to AIM and trading in the new shares is expected to commence on 4 February 2009.
--ENDS--
ENQUIRIES:
HENDERSON MORLEY PLC 0121 442 4600
Andrew Knight, Chairman
BISHOPSGATE COMMUNICATIONS LTD 0207 562 3350
(Public Relations)
Maxine Barnes
Nick Rome
BREWIN DOLPHIN INVESTMENT BANKING 0113 241 0126
(Nominated Adviser)
Neil Baldwin
HYBRIDAN LLP 0203 159 5085
(Broker)
Claire Noyce/Stephen Austin
Notes to Editors:
Henderson Morley was founded in 1996 with the objective of developing its anti viral application (Ionic Contra Viral Therapy (ICVT). ICVT is the Lead Platform and has been developed in-house and HML wholly owns the patent IPR.
Further information on Henderson Morley plc can be accessed through the Company's website at www.henderson-morley.com
Related Shares:
HML.L